OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Coenzyme Q10 displays antidepressant-like activity with reduction of hippocampal oxidative/nitrosative DNA damage in chronically stressed rats
Sawsan Aboul‐Fotouh
Pharmacology Biochemistry and Behavior (2013) Vol. 104, pp. 105-112
Closed Access | Times Cited: 86

Showing 1-25 of 86 citing articles:

Role of oxidative stress in Alzheimer's disease
Wenjuan Huang, Xia Zhang, Weiwei Chen
Biomedical Reports (2016) Vol. 4, Iss. 5, pp. 519-522
Open Access | Times Cited: 847

A Meta-Analysis of Oxidative Stress Markers in Depression
Tao Liu, Shuming Zhong, Xiaoxiao Liao, et al.
PLoS ONE (2015) Vol. 10, Iss. 10, pp. e0138904-e0138904
Open Access | Times Cited: 416

Oxidative stress as an etiological factor and a potential treatment target of psychiatric disorders. Part 2. Depression, anxiety, schizophrenia and autism
Irena Smaga, Ewa Niedzielska, Maciej Gawlik, et al.
Pharmacological Reports (2015) Vol. 67, Iss. 3, pp. 569-580
Closed Access | Times Cited: 236

Cognitive remission: a novel objective for the treatment of major depression?
Beatrice Bortolato, Kamilla Woznica Miskowiak, Cristiano A. Köhler, et al.
BMC Medicine (2016) Vol. 14, Iss. 1
Open Access | Times Cited: 222

The Glutathione System: A New Drug Target in Neuroimmune Disorders
Gerwyn Morris, George Anderson, Olivia Dean, et al.
Molecular Neurobiology (2014) Vol. 50, Iss. 3, pp. 1059-1084
Closed Access | Times Cited: 183

Shared metabolic and immune-inflammatory, oxidative and nitrosative stress pathways in the metabolic syndrome and mood disorders
de Melo, Sandra Odebrecht Vargas Nunes, George Anderson, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2017) Vol. 78, pp. 34-50
Closed Access | Times Cited: 160

Oxidative/Nitrosative Stress and Immuno-inflammatory Pathways in Depression: Treatment Implications
George Anderson, Michaël Maes
Current Pharmaceutical Design (2014) Vol. 20, Iss. 23, pp. 3812-3847
Closed Access | Times Cited: 139

A mitochondrial bioenergetic basis of depression
N. Jennifer Klinedinst, William T. Regenold
Journal of Bioenergetics and Biomembranes (2014) Vol. 47, Iss. 1-2, pp. 155-171
Closed Access | Times Cited: 132

Novel Therapeutic Targets in Depression and Anxiety: Antioxidants as a Candidate Treatment
Ying Xu, Chuang Wang, Jonathan Klabnik, et al.
Current Neuropharmacology (2014) Vol. 12, Iss. 2, pp. 108-119
Open Access | Times Cited: 119

Near-infrared photobiomodulation combined with coenzyme Q10 for depression in a mouse model of restraint stress: reduction in oxidative stress, neuroinflammation, and apoptosis
Farzad Salehpour, Fereshteh Farajdokht, Paolo Cassano, et al.
Brain Research Bulletin (2018) Vol. 144, pp. 213-222
Open Access | Times Cited: 107

Coenzyme Q10 as a treatment for fatigue and depression in multiple sclerosis patients: A double blind randomized clinical trial
Meisam Sanoobar, Parvin Dehghan, Mohammad Khalili, et al.
Nutritional Neuroscience (2015) Vol. 19, Iss. 3, pp. 138-143
Closed Access | Times Cited: 96

Erinacine A-Enriched Hericium erinaceus Mycelium Produces Antidepressant-Like Effects through Modulating BDNF/PI3K/Akt/GSK-3β Signaling in Mice
Chun‐Hung Chiu, Charng-Cherng Chyau, Chin‐Chu Chen, et al.
International Journal of Molecular Sciences (2018) Vol. 19, Iss. 2, pp. 341-341
Open Access | Times Cited: 88

Coenzyme Q10 Depletion in Medical and Neuropsychiatric Disorders: Potential Repercussions and Therapeutic Implications
Gerwyn Morris, George Anderson, Michael Berk, et al.
Molecular Neurobiology (2013) Vol. 48, Iss. 3, pp. 883-903
Open Access | Times Cited: 87

Investigation of protective effects of coenzyme Q10 on impaired synaptic plasticity in a male rat model of Alzheimer’s disease
Hamidreza Komaki, Nafiseh Faraji, Alireza Komaki‬, et al.
Brain Research Bulletin (2019) Vol. 147, pp. 14-21
Closed Access | Times Cited: 74

DNA Damage in Major Psychiatric Diseases
Muhammad Ummear Raza, Turan Tufan, Yan Wang, et al.
Neurotoxicity Research (2016) Vol. 30, Iss. 2, pp. 251-267
Open Access | Times Cited: 62

Targeting the immune system in the treatment of bipolar disorder
Joshua D. Rosenblat
Psychopharmacology (2019) Vol. 236, Iss. 10, pp. 2909-2921
Closed Access | Times Cited: 60

Curcumin in antidepressant treatments: An overview of potential mechanisms, pre‐clinical/clinical trials and ongoing challenges
Yinfeng Zhang, Li Li, Jinfeng Zhang
Basic & Clinical Pharmacology & Toxicology (2020) Vol. 127, Iss. 4, pp. 243-253
Closed Access | Times Cited: 50

Neuroprotective effects of coenzyme Q10 on neurological diseases: a review article
Shokufeh Bagheri, Rasool Haddadi, Sahar Saki, et al.
Frontiers in Neuroscience (2023) Vol. 17
Open Access | Times Cited: 20

Beyond Monoamines-Novel Targets for Treatment-Resistant Depression: A Comprehensive Review
Joshua D. Rosenblat, Roger S. McIntyre, Gilberto Sousa Alves, et al.
Current Neuropharmacology (2015) Vol. 13, Iss. 5, pp. 636-655
Open Access | Times Cited: 58

Guanosine prevents behavioral alterations in the forced swimming test and hippocampal oxidative damage induced by acute restraint stress
Luis E.B. Bettio, Andiara E. Freitas, Vivian B. Neis, et al.
Pharmacology Biochemistry and Behavior (2014) Vol. 127, pp. 7-14
Open Access | Times Cited: 57

Lipopolysaccharide repeated challenge followed by chronic mild stress protocol introduces a combined model of depression in rats: Reversibility by imipramine and pentoxifylline
Alshaimaa A. Elgarf, Sawsan Aboul‐Fotouh, Hadwa A. Abd-Alkhalek, et al.
Pharmacology Biochemistry and Behavior (2014) Vol. 126, pp. 152-162
Closed Access | Times Cited: 56

Evaluating the Effect of Coenzyme Q10 Augmentation on Treatment of Bipolar Depression
Maryam Mehrpooya, Fatemeh Yasrebifar, Mohammad Haghighi, et al.
Journal of Clinical Psychopharmacology (2018) Vol. 38, Iss. 5, pp. 460-466
Closed Access | Times Cited: 47

Nephroprotective activity of Combretum micranthum G. Don in cisplatin induced nephrotoxicity in rats: In-vitro, in-vivo and in-silico experiments
Mabozou Kpemissi, Kwashie Eklu-Gadégbéku, Veeresh Prabhakar Veerapur, et al.
Biomedicine & Pharmacotherapy (2019) Vol. 116, pp. 108961-108961
Open Access | Times Cited: 44

Combination of Omega 3 and Coenzyme Q10 Exerts Neuroprotective Potential Against Hypercholesterolemia-Induced Alzheimer's-Like Disease in Rats
Ghadha Ibrahim Fouad
Neurochemical Research (2020) Vol. 45, Iss. 5, pp. 1142-1155
Closed Access | Times Cited: 42

Validation of prenatal versus postnatal valproic acid rat models of autism: A behavioral and neurobiological study
Esraa M. Elnahas, Sally A. Abuelezz, Magda I. Mohamad, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2020) Vol. 108, pp. 110185-110185
Closed Access | Times Cited: 41

Page 1 - Next Page

Scroll to top